Skip to main content
. 2022 Apr 26;13:856410. doi: 10.3389/fphar.2022.856410

TABLE 1.

Demographics and co-morbidities.

Demographics  EF Control p-value
N 60 60
Age 35.2 (11.9) 36.6 (13.6) 0.546 a
Sex (f/m) 33/27 (55%/45%) 32/28 (53%/47%) 0.855 b
Height (m) 1.73 (0.08) 1.71 (0.10) 0.383 a
Weight (kg) 72.3 (17.0) 70.6 (14.5) 0.537 a
BMI (kg/m2) 24.1 (4.9) 23.8 (3.4) 0.755 a
 Smokers 25 (41.7%) 19 (31.7%) 0.256 b
-Number of cigarettes/day 10.6 (7.7) 12.0 (7.8) 0.582 a
 Co-Morbidities, overall 16 (26.7%) 6 (10.0%) 0.018 b
-Hypertension 4 (6.7%) 0 (0%)
-Hashimoto’s thyroiditis 1 (1.7%) 2 (3.3%)
-Osteoporosis 2 (3.3%) 0 (0%)
-Hypothyroidism/Thyroidectomy 2 (3.3%) 0 (0%)
-Hyperuricemia 0 (0%) 1 (1.7%)
-Myoma uteri/Uterine polyp 1 (1.7%) 1 (1.7%)
-Allergic rhinitis 1 (1.7%) 0 (0%)
-Chronic sinusitis 1 (1.7%) 0 (0%)
-Hip osteoarthritis 1 (1.7%) 0 (0%)
-Dyslipidemia 0 (0%) 1 (1.7%)
-Episodes of headache 0 (0%) 1 (1.7%)
-Gastroesophageal reflux disease 1 (1.7%) 0 (0%)
-Nephrolithiasis 1 (1.7%) 0 (0%)
-Psoriasis 1 (1.7%) 0 (0%)

Data are n (%), mean (SD).

a

Student’s t-test.

b

Chi-Square test.